Showing results (141-150 of 279) with videos related to
Sort By:
Pageof 28
Blood Advances|October 7, 2020
TNFR2 is required for RIP1-dependent cell death in human leukemiaJúlia Aguadé-Gorgorió, Scott McComb, Cornelia Eckert, et al.Haematologica|December 14, 2004
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasmsThorben Kracht, Martin Schrappe, Sabine Strehl, et al.The Journal of Experimental Medicine|May 4, 2011
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemiasChen Shochat, Noa Tal, Obul R Bandapalli, et al.Haematologica|August 10, 2012
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolPetra Dörge, Barbara Meissner, Martin Zimmermann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.Leukemia & Lymphoma|February 1, 2017
Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trialKathinka Krull, Marina Kunstreich, Janina Klasen-Sansone, et al.The New England Journal of Medicine|April 26, 2023
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic LeukemiaInge M van der Sluis, Paola de Lorenzo, Rishi S Kotecha, et al.Blood|May 31, 2002
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALLMarja J Willemse, Taku Seriu, Klaudia Hettinger, et al.British Journal of Haematology|February 26, 2016
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemiaJan Zuna, Anja Moericke, Mari Arens, et al.Cancers|November 27, 2021
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved DiagnosticsPhilippe Chouvarine, Željko Antić, Jana Lentes, et al.Pageof 28